Sanofi (SNY) Amortization - Intangibles (2009 - 2025)

Sanofi has disclosed Amortization - Intangibles across 17 years of filings, most recently posting -$2.1 billion for Q4 2025.

• In Q4 2025, Amortization - Intangibles fell 10.61% year-over-year to -$2.1 billion; the TTM figure through Dec 2025 stood at -$4.4 billion (down 32.95% YoY), while the FY2025 annual figure was -$2.1 billion, down 9.21% from the prior year.
• Amortization - Intangibles came in at -$2.1 billion for Q4 2025 at Sanofi, down from -$1.4 billion in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of -$419.7 million in Q1 2025 to a low of -$2.1 billion in Q4 2025.
• Average Amortization - Intangibles over 5 years is -$907.7 million, with a median of -$525.3 million recorded in 2023.
• Year-over-year, Amortization - Intangibles climbed 28.02% in 2024 and tumbled 228.64% in 2025.
• Over 5 years, Amortization - Intangibles stood at -$1.8 billion in 2021, then declined by 1.83% to -$1.8 billion in 2022, then declined by 11.71% to -$2.1 billion in 2023, then increased by 9.1% to -$1.9 billion in 2024, then slipped by 10.61% to -$2.1 billion in 2025.
• Per Business Quant data, the three most recent Amortization - Intangibles figures were -$2.1 billion in Q4 2025, -$1.4 billion in Q3 2025, and -$427.9 million in Q2 2025.